4D Presents at IHMC 2018

June 27, 2018

LEEDS, England, June 27, 2018 /PRNewswire/ -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announced that the Company's Chief Scientific Officer, Dr. Alex Stevenson, has spoken at the International Human Microbiome...

Source URL: https://www.prnewswire.com/news-releases/4d-presents-at-ihmc-2018-686652161.html

Browse News

Verve Industrial Protection Announces the Release of Version 6.0 - The First True End Point Management Detection and Response Platform for Industrial IOT & Industrial Control Systems

Berlin Cures strengthens Business Advisory Board with the appointments of Ulf Berg, Ph.D., and Dragan Grabulovski, Ph.D.

LUMICKS Collaborates with AstraZeneca and the University of Cambridge to Form the First Ever Center of Excellence for Dynamic Single-Molecule Analysis for Accelerated Drug Discovery and Biology